Key Metrics
CiteScore 

91.9
Eigenfactor 

0.1 - 0.5
Impact Factor 

>= 25
Scite Index 

0.90 5-Year SI

SJR 

Q1Biochemistry, Genetics and Molecular Biology (all)

SNIP 

12.17
Recommended pre-submission checks
Powered by 

Topics Covered on Nature Medicine
Nature Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Monthly |
| General Details |
View less
Planning to publish in Nature Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Nature Medicine
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update.
- 13 May 2026
- Nature medicine
Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial.
- 13 May 2026
- Nature medicine
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.
- 13 May 2026
- Nature medicine
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.
- 12 May 2026
- Nature medicine
Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas.
- 12 May 2026
- Nature medicine
Data-Driven Decision Support in Obesity Management Commission: enabling more equitable and personalized obesity care.
- 12 May 2026
- Nature medicine
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update.
- 13 May 2026
- Nature medicine
Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial.
- 13 May 2026
- Nature medicine
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.
- 13 May 2026
- Nature medicine
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.
- 12 May 2026
- Nature medicine
Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas.
- 12 May 2026
- Nature medicine
Data-Driven Decision Support in Obesity Management Commission: enabling more equitable and personalized obesity care.
- 12 May 2026
- Nature medicine